RH&PARTNER Investment Funds SICAV-RH&P Global Life Sciences Fund I Cap CHF/ LU1120849671 /
| NAV01/10/2024 | Chg.-0.1900 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 91.0100CHF | -0.21% | reinvestment | Equity | FundPartner Sol.(EU) ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 03/10/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 26/02/2024 | Prospectus | 2024 | German | 1,165.74 KB |
| 19/02/2024 | PRIIP Key Information Document | 2024 | German | 108.23 KB |
| 31/12/2023 | Account statment | 2023 | German | 8,255.51 KB |
| 30/06/2023 | Semi-annual report | 2023 | German | 1,469.03 KB |
| 20/06/2022 | Key Investor Information | 2022 | German | 74.81 KB |
